Bile Acid Sequestrants Market Size & Share, by Type (Colestid, Colestipol, Prevalite, Questran); Application (Hyperlipidemia, Liver Cirrhosis, Hyperthyroidism, T2D); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2024-2036

  • Report ID: 5452
  • Published Date: Dec 11, 2023
  • Report Format: PDF, PPT

Companies Dominating the Bile Acid Sequestrants Market

top-features-companies
    • Pfizer Inc.
      • Company Overview
      • Business Planning
      • Main Product Offerings
      • Financial Execution
      • Main Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • AstraZeneca Plc
    • Ecogene
    • Novartis International AG
    • Sanofi S.A.
    • Amgen Inc.
    • Merck & Co., Inc.
    • AbbVie Inc.
    • GlaxoSmithKline plc.
    • Octapharma AG

Browse Key Market Insights with Data Illustration:

In-the-news

In The News

  • Pfizer Inc. released top-line outcomes from the Phase 2b study of vupanorsen (PF-07285557), an investigational treatment being formulated for possible symptoms in cardiovascular (CV) risk reduction and severe hypertriglyceridemia (SHTG). The study showed that vupanorsen accomplished a statistically substantial limiting of non- HDL-C, triglycerides, and other lipoproteins associated with cardiovascular disease.
  • The U.S. Food and Drug Administration (FDA) Center for Drug Evaluation and Research (CDER) has obtained the Biologics License Application (BLA) for nirsevimab for the prohibition of respiratory syncytial virus (RSV) lower respiratory tract disease in toddlers and infants coming or during their first RSV season and for kids up to 24 months of age who stay exposed to acute RSV disease through their second RSV season.

Author Credits:  Radhika Gupta, Shivam Bhutani


  • Report ID: 5452
  • Published Date: Dec 11, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

The increasing cases of hyperlipidemia worldwide will majorly drive the market growth of the bile acid sequestrants market.

The market size of the bile acid sequestrants market is expected to get a CAGR of approximately 8% over the forecast period, i.e., 2024-2036.

The major players in the market are Pfizer Inc., AstraZeneca Plc, Ecogene, Novartis International AG, Sanofi S.A., Amgen Inc., Merck & Co., Inc., AbbVie Inc., GlaxoSmithKline plc., Octapharma AG, Daiichi Sankyo Company, Limited, Eisai Co., Ltd., Mochida Pharmaceutical Co., Ltd., Astellas Pharma Inc.

The hospital pharmacies segment is anticipated to reap the largest market size with almost 38% by the end of 2036 and demonstrate substantial growth scopes.

The market in the North American region is expected to have the largest market share by the end of 2036 and provide more business opportunities in the future.
Inquiry Before Buying Request Free Sample
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying